Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-31
1999-11-30
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 4, 514 12, 514 21, 530300, 530324, 530325, 530326, 530327, 530328, A61K 3800
Patent
active
059942924
ABSTRACT:
The present invention is interferon-inducible protein 10 and fragments and analogs of interferon-inducible protein 10 as inhibitors of angiogenesis. The present invention is also the use of interferon-inducible protein 10 (IP-10) as well as fragments and analogs of IP-10 as potent inhibitors of angiogenesis. IP-10 profoundly inhibited basic fibroblast growth factor (bFGF)-induced neovascularization in immunocompromised mammals. In addition, IP-10, is useful in a dose-dependent fashion in suppressing endothelial cell differentiation into tubular capillary structures.
REFERENCES:
patent: 5086164 (1992-02-01), Maione et al.
patent: 5112946 (1992-05-01), Maione et al.
patent: 5346686 (1994-09-01), Lyle et al.
patent: 5474981 (1995-12-01), Leder et al.
patent: 5728377 (1998-03-01), Sarris et al.
Angiolillo et al, Human Interferon-inducible Protein 10 is a Potent Inhibitor of Angiogenesis In Vivo, The Journal of Experimental Medicine vol. 182, pp. 155-162, Jul. 1995.
Strieter et al, Interferon .gamma.-Inducible Protein 10 (IP-10), a Member of the C-X-C Chemokine Family, is an Inhibitor of Angiogenesis, Biochemical and Biophysical Research Communications, vol. 210, No. 1, pp. 51-57, May 5, 1995.
Ohmori et al, IFN-.gamma. Selectively Inhbitis Lipopolysaccharide-Inducible JE/Monocyte Chemoattractant Protein-1 and KC/BRO/Melanoma Growth-Stimulating Activity Gene Expression in Mouse Peritoneal Macrophages, The Journal of Immunology, vol. 153, No. 5, pp. 2204-2212, Sep. 1, 1994.
Bedard et al, Cytokine-Induced Expression of mRNAs for Chemotactic Factors in Human Synovial Cells and Fibroblasts, Journal of Cellular Physiology, vol. 154, No. 2, pp. 433-441, Feb. 1993.
Luster et al, Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells, Proc. Natl. Acad. Sci. USA, vol. 84, pp. 2868-2871, May 1987.
Presta et al, New Aspects of Blood Vessel Growth: Tumor and Tissue-Derived Angiogenesis Factors, Haemostasis 18:6-17 (1988).
Folkman et al, Angiogenic Factors, Science, vol. 235, pp. 442-447, Jan. 23, 1987.
Gupta et al, Inhibition of Endothelial Cell Proliferation by Platelet Factor-4 Involves a Unique Action on S Phase Progression, The Journal of Cell Biology, vol. 127, No. 4, pp. 1121-1127, Nov. 1994.
Luster et al, Genomic Characteriztion of a Gamma-Interferon-Inducible Gene (IP-10) and Identification of an Interferon-Inducible Hypersensitive Site, Molecular and Cellular Biology, vol. 7, No. 10, pp. 3723-3731, Oct. 1987.
Sarris et al, Human Interferon-inducible Protein 10: Expression and Purification of Recombinant Protein Demonstrate Inhibition of Early Human Hematopoietic Progenitors, J. Exp. Med., vol. 178, pp. 1127-1132, Sep. 1993.
Maione et al, Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides, Science, vol.247, pp. 77-79, Jan. 5, 1990.
D'Amore, Antiangiogenesis as a Strategy for Antimetastasis, Seminars in Thrombosis and Hemostasis, vol. 14, No. 1, pp. 73-78, 1988.
Luster et al, IP-10, a -C-X-C- Chemokine, Elicits a Potent Thymus-dependent Antitumor Response In Vivo, J. Exp. Med., vol. 178, pp. 1057-1065, Sep. 1993.
Luster et al, .gamma.-Interferon Transcriptionally Regulates an Early-Response Gene Containing Homology to Platelet Proteins, Nature, vol. 315, pp. 672-676, Jun. 20, 1985.
Battegay, "Angiogenesis: Mechanistic Isusights" (1995), Biosis Abstract # 95:443403.
O'Reilly, "Angiostatin" (1994), Biosis Abstract #94:549066.
Angiolillo Anne L.
Sgadari Cecilia
Tosato Giovanna
Delaney Patrick R.
The United States of America as represented by the Department of
Tsang Cecilia J.
LandOfFree
Interferon-inducible protein 10 is a potent inhibitor of angioge does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interferon-inducible protein 10 is a potent inhibitor of angioge, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon-inducible protein 10 is a potent inhibitor of angioge will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672450